The available database comprises research projects in Fisheries, Aquaculture, Seafood Processing and Marine Biotechnology active in the time period 2003-2022.
BlueBio is an ERA-NET COFUND created to directly identify new and improve existing ways of bringing bio-based products and services to the market and find new ways of creating value from in the blue bioeconomy.

More information on the BlueBio project and participating funding organizations is available on the BlueBio website: www.bluebioeconomy.eu

Last Update: 2024/06/19

SaliVax
Aquaculture
Marine Biotechnology
DNA vaccine directed against salmon lice saliva
National Programme
National
Aina-Cathrine Øvergård
Aina-Cathrine.Overgard@uib.no
UiB - University of Bergen (Norway)
NA
2022
2025
€ 700,000
https://www.fhf.no/prosjekter/prosjektbasen/901760/
Salmon lice cause a number of disease and welfare challenges as a result of an intensive lice treatment regime, and are an obstacle to further growth in the industry. A measure that can provide a significant improvement in relation to the current welfare situation is a salmon lice vaccine. The most promising vaccine candidates that have been tested so far have been based on the fact that antibodies work or are taken up via the louse's gut. However, this has not led to the development of a commercial vaccine, as the antibodies from the salmon are probably quickly degraded by digestive enzymes in the louse's gut. This project will thus see whether proteins that work at the interface between the louse and the salmon can have greater potential as vaccine antigens. Goals: • To investigate whether proteins that are important in the interaction between salmon lice and salmon (the parasite-host interaction) can be used in a salmon lice vaccine, by trying to clarify whether salmon have an inherent resistance mechanism that is dampened by components in the salmon lice's secretions, and if it is possible to inhibit this so that the salmon itself activates the necessary immune responses against the salmon lice. • To look more generally at the possibilities of increasing mucosal levels of antibodies using DNA vaccines, where one can make use of different plasmid designs, molecular adjuvants and administration methods to achieve this.
Genetic; Salmon; Engineering; Parasite; Fish; Fish health; Vaccines development;
Not associated to marine areas
map png
If there is any incorrect or missing information on this project please access here or contact bluebio.database@irbim.cnr.it
/* */